Relationship between Epstein–Barr Virus Nuclear Antigen and DNA Genome Number in Superinfected and Induced Lymphoblastoid Cell Lines

References

1. Ablashi D. V., Easton J. M., Armstrong G. R., Bengali Z. 1979; Extraction of soluble antigens of Epstein–Barr virus, Herpesvirus saimiri, and Herpesvirus ateles with the use of glycine. Journal of the National Cancer Institute 62:1173–1175
   [Google Scholar]
2. Břicháček B., Suchánková A., Hirsch I., Šíbl O., Řezáčová D., Závadová H., Vonka V. 1981; Presence of Epstein–Barr virus DNA in tonsillar tissues. Acta virologica 25:361–370
   [Google Scholar]
3. Ernberg I., Andersson-Anvret M., Klein G., Lundin L., Killander D. 1977; Relationship between amount of Epstein–Barr virus-determined nuclear antigen per cell and number of EBV-DNA copies per cell. Nature, London 266:269–270
   [Google Scholar]
4. Hirsch I., Kuchlerová L., Břicháček B., Suchánková A., Vonka V. 1979; Blocking of acid-fixed nuclear binding of Epstein–Barr virus nuclear antigen (EBNA) by different DNA species. Journal of General Virology 44:849–852
   [Google Scholar]
5. Johnson D. R., Ohno S., Kaschka-Dierich C., Fleckenstein B., Klein G. 1981; Relationship between Herpes-virus ateles-associated nuclear antigen (HATNA) and the number of virus genome equivalents in HVA-carrying lymphoid lines. Journal of General Virology 52:221–226
   [Google Scholar]
6. Kallin B., Luka J., Klein G. 1979; Immunochemical characterization of Epstein–Barr virus-associated early and late antigens in n-butyrate treated P3HR-1 cells. Journal of Virology 32:710–716
   [Google Scholar]
7. Kamata T., Tanaka S., Aikawa S., Hinuma Y., Watanabe Y. 1979; A possible function of Epstein–Barr virus-determined nuclear antigen (EBNA): stimulation of chromatin template activity in vitro. Virology 95:222–226
   [Google Scholar]
8. Kamata T., Takaki K., Hinuma Y., Watanabe Y. 1981; Protein kinase activity associated with Epstein–Barr virus-determined nuclear antigen. Virology 113:512–520
   [Google Scholar]
9. Klein G., Luka J., Zeuthen J. 1979; Epstein–Barr virus (EBV)-induced transformation and the role of the nuclear antigen (EBNA). Cold Spring Harbor Symposia on Quantitative Biology 44:253–261
   [Google Scholar]
10. Lenoir G., Berthelon M. C., Favre M. C., De Thé G. 1975; Characterization of Epstein–Barr virus (EBV) antigens. II. Detection of early antigen(s) using anticomplement immunofluorescence (ACIF) and complement-fixation (CF) test. Biomedicine 23:461–464
    [Google Scholar]
11. Lowry O. H., Rosebrough N. J., Farr A. L., Randall R. J. 1951; Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry 193:265–275
    [Google Scholar]
12. Luka J., Siegert W., Klein G. 1977; Solubilisation of the Epstein–Barr virus determined nuclear antigen and its characterization as a DNA-binding protein. Journal of Virology 22:1–8
    [Google Scholar]
13. Luka J., Jörnvall H., Klein G. 1980; Purification and biochemical characterization of the Epstein–Barr virus-determined nuclear antigen and an associated protein with a 53, 000 dalton subunit. Journal of Virology 35:592–602
    [Google Scholar]
14. Ohno S., Luka J., Lindahl T., Klein G. 1977; Identification of a purified complement-fixing antigen as the Epstein–Barr virus-determined nuclear antigen (EBNA) by its binding to metaphase chromosomes. Proceedings of the National Academy of Sciences, U. S. A 74:1605–1609
    [Google Scholar]
15. Pikler G. M., Pearson G. R., Spelsberg T. C. 1978; Isolation of the Epstein–Barr virus nuclear antigen from chromatin preparations. In Oncogenesis and Herpesviruses HI pp 243–247 Edited by De The G., Henle W., Rapp F. Lyon: IARC Scientific Publications;
    [Google Scholar]
16. Reedman B. M., Klein G. 1973; Cellular localization of an Epstein–Barr virus (EBV)-associated complement fixing antigen in producer and non-producer lymphoblastoid cell lines. International Journal of Cancer II:499–520
    [Google Scholar]
17. Roberts I. W., Roberts C. W., Craig N. 1978; Escherichia coli recA gene product inactivates phage λ repressor. Proceedings of the National Academy of Sciences, U. S. A 75:4714–4718
    [Google Scholar]
18. Shapiro I. M., Luka J., Andersson-Anvret M., Klein G. 1979; Relationship between Epstein–Barr virus genome number, amount of nuclear antigen, and early antigen inducibility in diploid and tetraploid lymphoma cells of related origin. Intervirology 12:19–25
    [Google Scholar]
19. Shapiro I., Volsky D. J., Saemundsen A. K., Anisimová E., Klein G. 1982; Infection of the human T-cell-derived leukemia line molt-4 by Epstein–Barr virus (EBV): induction of EBV-determined antigens and virus reproduction. Virology 120:171–181
    [Google Scholar]
20. Suzuki M., Hinuma Y. 1975; Relationship between Epstein–Barr virus-associated nuclear antigen and cell viability in human cell lines. Gann 66:103–105
    [Google Scholar]
21. Svedmyr E., Jondal M. 1975; Cytotoxic cells specific for B cell lines transformed by Epstein–Barr virus are present in patients with infectious mononucleosis. Proceedings of the National Academy of Sciences, U. S. A 72:1622–1626
    [Google Scholar]
22. Tjian R. 1981; T antigen binding and the control of SV 40 gene expression. Cell 26:1–2
    [Google Scholar]
23. Volsky D. J., Klein G., Volsky B., Shapiro L. 1981; Production of infectious Epstein–Barr virus in mouse lymphocytes. Nature, London 293:399–401
    [Google Scholar]
24. Vonka V., Hirsch I. 1982; Epstein–Barr-virus nuclear antigen. Progress in Medical Virology 28:145–179
    [Google Scholar]
25. Vonka V., Benyesh-Melnick M., Lewis R. T., Wimberly I. 1970a; Some properties of the soluble (S) antigen of cultured lymphoblastoid cell lines. Archiv für die gesamte Virusforschung 31:113–124
    [Google Scholar]
26. Vonka V., Benyesh-Melnick M., McCombs R. M. 1970b; Antibodies in human sera to soluble and viral antigens found in Burkitt lymphoma and other lymphoblastoid cell lines. Journal of the National Cancer Institute 44:865–872
    [Google Scholar]
27. Vonka V., Kutinová L., Drobník J., Bräuerová J. 1972; Increase of Epstein–Barr virus positive cells in EB3 cultures after treatment with cis-dichloro-diamine-platinum. Journal of the National Cancer Institute 48:1277–1281
    [Google Scholar]
28. Vonka V., Šibl O., Suchánková A., Simonová I., Závadová H. 1977; Epstein–Barr virus antibodies in tonsillar carcinoma patients. International Journal of Cancer 19:456–459
    [Google Scholar]
29. Yajima Y., Nonoyama M. 1976; Mechanisms of infection with Epstein–Barr virus. I. Viral DNA replication and formation of non-infectious virus particles in superinfected Raji cells. Journal of Virology 19:187–194
    [Google Scholar]